Sheel Patel
Hematology & Oncology · St Petersburg, FLNPI 1942566567
Payments from drug & device makers
Across 263 payments — averaging $19.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$668
- Novartis$448
- Amgen$408
- Johnson & Johnson$375
- Astellas Pharma US Inc$354
- Daiichi Sankyo Inc.$330
- plus $3K from 32 others
What the payments were for
- Food & beverage$5,05597%
- Education$1673%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 30 | $668 |
| Novartis | 23 | $448 |
| Amgen | 20 | $408 |
| Johnson & Johnson(2 entities) | 20 | $375 |
| Astellas Pharma US Inc | 14 | $354 |
| Daiichi Sankyo Inc. | 7 | $330 |
| E.r. Squibb & Sons, L.L.C. | 22 | $318 |
| Merck | 18 | $314 |
| Lilly USA, LLC | 17 | $297 |
| Teva Pharmaceuticals USA, Inc. | 2 | $163 |
| Eisai Inc. | 8 | $158 |
| Pfizer | 9 | $135 |
| Boehringer Ingelheim | 6 | $111 |
| Seagen Inc. | 7 | $99 |
| Pharmacyclics LLC, An Abbvie Company | 4 | $91 |
| Incyte Corporation | 5 | $89 |
| Bayer | 4 | $68 |
| Genentech USA, Inc. | 4 | $65 |
| EMD Serono, Inc. | 4 | $65 |
| Gilead(2 entities) | 4 | $59 |
| Bristol Myers Squibb | 4 | $58 |
| Array Biopharma Inc | 3 | $57 |
| AbbVie | 3 | $51 |
| Rigel Pharmaceuticals, Inc. | 3 | $48 |
| Puma Biotechnology, Inc. | 3 | $47 |
| Karyopharm Therapeutics Inc. | 2 | $40 |
| Portola Pharmaceuticals, LLC | 2 | $39 |
| Foundation Medicine, Inc. | 1 | $38 |
| Jazz Pharmaceuticals Inc. | 2 | $35 |
| Helsinn Therapeutics (U.S.), Inc. | 2 | $34 |
| Ipsen Biopharmaceuticals, Inc | 2 | $26 |
| Exelixis Inc. | 2 | $24 |
| Sanofi | 1 | $20 |
| Tersera Therapeutics LLC | 1 | $20 |
| Beigene USA, Inc. | 1 | $19 |
| Aurobindo Pharma USA, Inc. | 1 | $18 |
| AMAG Pharmaceuticals, Inc. | 1 | $16 |
| Acrotech Biopharma Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INJECTAFER$250
- LYNPARZA$118
- IMFINZI$112
How this compares
$5,221 in reported general payments places this provider in the 35th percentile of 694 hematology & oncology providers in Florida.
Other hematology & oncology in St Petersburg
- Carl LandgrenMiami$47.8M
- Julio ChavezTampa$16.4M
- Steven AttiaJacksonville$13.9M
- Santosh NairOrange City$13.5M
- Frederick LockeTampa$12.8M
- Tarek MekhailOrlando$11.2M
- Carlos AlemanyOrlando$10.9M
- Thomas GeorgeGainesville$10.3M
- Sikander AilawadhiJacksonville$9.8M
- Richard KimTampa$8.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.